Showing results (291-300 of 398) with videos related to

Sort By:
Pageof 40
Clinical Pharmacology and Therapeutics|October 1, 1996
Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylationD R Jones, J C Gorski, B D Haehner, et al.
Epidemiology and Infection|January 8, 2011
Escherichia coli O157: comparing awareness of rural residents and visitors in livestock farming areasC D R Jones, C Hunter, A P Williams, et al.
British Journal of Urology|March 1, 1988
X-ray microscopy of the prostate glandR L Davies, D R Jones, T J Harrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein bindingD R Jones, S D Hall, E K Jackson, et al.
British Journal of Urology|November 1, 1990
Origin and structure of benign prostatic hyperplasiaD R Jones, M C Parkinson, G J Griffiths, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 7, 2002
Reversible and irreversible inhibition of CYP3A enzymes by tamoxifen and metabolitesXue-Jun Zhao, D R Jones, Ying-Hong Wang, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 5, 1999
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamilyJ C Gorski, D R Jones, M A Hamman, et al.
British Journal of Clinical Pharmacology|September 6, 2000
Intravenous diltiazem and CYP3A-mediated metabolismA L Masica, N E Azie, D C Brater, et al.
BMJ (Clinical Research Ed.)|June 14, 2000
Empirical assessment of effect of publication bias on meta-analysesA J Sutton, S J Duval, R L Tweedie, et al.
The Annals of Thoracic Surgery|March 1, 1994
Potential application of p53 as an intermediate biomarker in Barrett's esophagusD R Jones, A G Davidson, C L Summers, et al.
Pageof 40